Methylprednisolone Transdermal Patch 5mg/day from Japan
7-day transdermal patch system releasing 5mg/day methylprednisolone for chronic pain management. HTS 3004.32.00.40 explicitly includes transdermal administration systems put up for retail therapeutic use.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Adhesive skin contact study and permeation rate data required
• Packaging must protect from humidity; declare moisture barrier specs
• Monitor for controlled substance scheduling if combined with opioids